Studies on the efficacy of pyrotinib in the treatment of HER-2 positive advanced solid tumors.
Volume: 38, Issue: 15_suppl, Pages: e15639 - e15639
Published: May 20, 2020
Abstract
e15639 Background: To explore the efficacy and safety of pyrotinib in the treatment of HER-2 positive advanced solid tumors patients. Methods: Patients with HER-2 positive advanced solid tumors in oncology department of our hospital from October 2018 to Janurary 2020 were collected. All the patients were given oral pyrotinib 400mg once a day in a 28-day cycle. The clinicopathological characteristics, treatment history, and curative effect were...
Paper Details
Title
Studies on the efficacy of pyrotinib in the treatment of HER-2 positive advanced solid tumors.
Published Date
May 20, 2020
Journal
Volume
38
Issue
15_suppl
Pages
e15639 - e15639
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History